(Posted By: Josi Creek)
An early check of registry data from women with multiple sclerosis who became pregnant while taking natalizumab (Tysabri) does not appear to raise concerns of miscarriages or abnormalities, researchers said here.
To read the full story, click HERE.
An early check of registry data from women with multiple sclerosis who became pregnant while taking natalizumab (Tysabri) does not appear to raise concerns of miscarriages or abnormalities, researchers said here.
To read the full story, click HERE.
